Stephen Thom

Person

  • Cheshire, GB

Patents Grantslast 30 patents

  • Information Patent Grant

    Sulfonamide carboxamide compounds

    • Patent number 12,221,434
    • Issue date Feb 11, 2025
    • Inflazome Limited
    • Matthew Cooper
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Sulfonamide carboxamide compounds

    • Patent number 12,012,392
    • Issue date Jun 18, 2024
    • Inflazome Limited
    • Matthew Cooper
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Sulfonamide carboxamide compounds

    • Patent number 11,981,667
    • Issue date May 14, 2024
    • Inflazome Limited
    • Matthew Cooper
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors

    • Patent number 11,926,600
    • Issue date Mar 12, 2024
    • Inflazome Limited
    • Matthew Cooper
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Sulfonamide carboxamide compounds

    • Patent number 11,773,058
    • Issue date Oct 3, 2023
    • Inflazome Limited
    • David Miller
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Processes

    • Patent number 11,724,988
    • Issue date Aug 15, 2023
    • Inflazome Limited
    • Daniel Schwizer
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Compounds

    • Patent number 11,623,922
    • Issue date Apr 11, 2023
    • Inflazome Limited
    • David Miller
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors

    • Patent number 11,613,542
    • Issue date Mar 28, 2023
    • Inflazome Limited
    • Matthew Cooper
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors

    • Patent number 11,542,255
    • Issue date Jan 3, 2023
    • Inflazome Limited
    • Matthew Cooper
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Sulfonamide carboxamide compounds

    • Patent number 11,518,739
    • Issue date Dec 6, 2022
    • Inflazome Limited
    • David Miller
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Sulfonamide carboxamide compounds

    • Patent number 11,465,992
    • Issue date Oct 11, 2022
    • Inflazome Limited
    • Matthew Cooper
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors

    • Patent number 11,370,776
    • Issue date Jun 28, 2022
    • Inflazome Limited
    • Matthew Cooper
    • G01 - MEASURING TESTING
  • Information Patent Grant

    Kinase inhibitors

    • Patent number 10,941,115
    • Issue date Mar 9, 2021
    • Oxular Acquisitions Limited
    • Thomas Matthew Baker
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Kinase inhibitors

    • Patent number 10,442,828
    • Issue date Oct 15, 2019
    • Topivert Pharma Limited
    • Matthew Colin Thor Fyfe
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Kinase inhibitors

    • Patent number 10,435,361
    • Issue date Oct 8, 2019
    • Topivert Pharma Limited
    • Thomas Matthew Baker
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Kinase inhibitors

    • Patent number 10,392,346
    • Issue date Aug 27, 2019
    • Topivert Pharma Limited
    • Thomas Matthew Baker
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Kinase inhibitors

    • Patent number 10,125,100
    • Issue date Nov 13, 2018
    • Respivert Limited
    • Thomas Matthew Baker
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Kinase inhibitors

    • Patent number 10,072,034
    • Issue date Sep 11, 2018
    • RESPIVERT LIMITED
    • Matthew Colin Thor Fyfe
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Urea derivatives useful as kinase inhibitors

    • Patent number 9,890,185
    • Issue date Feb 13, 2018
    • Respivert Limited
    • Matthew Colin Thor Fyfe
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Kinase inhibitors

    • Patent number 9,796,742
    • Issue date Oct 24, 2017
    • RESPIVERT LIMITED
    • Matthew Colin Thor Fyfe
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Kinase inhibitors

    • Patent number 9,790,174
    • Issue date Oct 17, 2017
    • Respivert Limited
    • Stephen Malcolm Thom
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Kinase inhibitors

    • Patent number 9,790,209
    • Issue date Oct 17, 2017
    • RESPIVERT LIMITED
    • Matthew Colin Thor Fyfe
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Kinase inhibitors

    • Patent number 9,783,556
    • Issue date Oct 10, 2017
    • RESPIVERT LIMITED
    • Matthew Colin Thor Fyfe
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Kinase inhibitors

    • Patent number 9,751,837
    • Issue date Sep 5, 2017
    • Respivert Limited
    • Thomas Matthew Baker
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Kinase inhibitors

    • Patent number 9,732,063
    • Issue date Aug 15, 2017
    • RESPIVERT LIMITED
    • Fritz-Frieder Frickel
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Pyrazolyl-ureas as kinase inhibitors

    • Patent number 9,701,670
    • Issue date Jul 11, 2017
    • RESPIVERT LIMITED
    • Claire Anne Marie Cariou
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Pyrimidine derivatives and their use in the treatment of cancer and...

    • Patent number 9,533,978
    • Issue date Jan 3, 2017
    • Sumitomo Dainippon Pharma Co., Ltd.
    • Nicholas James Bennett
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Kinase inhibitors

    • Patent number 9,481,648
    • Issue date Nov 1, 2016
    • Respivert Limited
    • Thomas Matthew Baker
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Purine derivatives

    • Patent number 8,895,570
    • Issue date Nov 25, 2014
    • AstraZeneca AB
    • Phillip Abbott
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Pyrimidline derivatives having immune modulating properties that ac...

    • Patent number 8,765,939
    • Issue date Jul 1, 2014
    • Astrazeneca AB
    • Nicholas J. Bennett
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

    • Publication number 20250115591
    • Publication date Apr 10, 2025
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PYRIDAZINE DERIVATIVES AS INHIBITORS OF NLRP3

    • Publication number 20240308977
    • Publication date Sep 19, 2024
    • HOFFMANN-LA ROCHE INC.
    • Lewis Scott AITKEN
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    COMPOUNDS

    • Publication number 20230121952
    • Publication date Apr 20, 2023
    • Inflazome Limited
    • Matthew COOPER
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

    • Publication number 20230037255
    • Publication date Feb 2, 2023
    • INFLAZOME LIMITED
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MACROCYCLIC SULFONYLAMIDE DERIVATIVES USEFUL AS NLRP3 INHIBITORS

    • Publication number 20220389031
    • Publication date Dec 8, 2022
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MACROCYCLIC SULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS

    • Publication number 20220289766
    • Publication date Sep 15, 2022
    • INFLAZOME LIMITED
    • Matthew COOPER
    • G01 - MEASURING TESTING
  • Information Patent Application

    ITACONIC ACID DERIVATIVES AND USES THEREOF INTREATING AN INFLAMMATO...

    • Publication number 20220265595
    • Publication date Aug 25, 2022
    • Sitryx Therapeutics Limited
    • Michael Liam COOKE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL SULFONEUREA COMPOUNDS

    • Publication number 20220106288
    • Publication date Apr 7, 2022
    • Inflazome Limited
    • Angus MACLEOD
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NLRP3 INHIBITORS

    • Publication number 20220106289
    • Publication date Apr 7, 2022
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL PROCESSES

    • Publication number 20220064125
    • Publication date Mar 3, 2022
    • Inflazome Limited
    • Daniel SCHWIZER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL COMPOUNDS

    • Publication number 20210261512
    • Publication date Aug 26, 2021
    • Inflazome Limited
    • David MILLER
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NOVEL SULFONEUREA COMPOUNDS

    • Publication number 20210163412
    • Publication date Jun 3, 2021
    • Inflazome Limited
    • Jonathan SHANNON
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS

    • Publication number 20210130359
    • Publication date May 6, 2021
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS

    • Publication number 20210130329
    • Publication date May 6, 2021
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

    • Publication number 20210122739
    • Publication date Apr 29, 2021
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS

    • Publication number 20210122716
    • Publication date Apr 29, 2021
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

    • Publication number 20200361895
    • Publication date Nov 19, 2020
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

    • Publication number 20200354341
    • Publication date Nov 12, 2020
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

    • Publication number 20200331850
    • Publication date Oct 22, 2020
    • Inflazome Limited
    • David MILLER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL COMPOUNDS

    • Publication number 20200331886
    • Publication date Oct 22, 2020
    • Inflazome Limited
    • David MILLER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

    • Publication number 20200317637
    • Publication date Oct 8, 2020
    • Matthew COOPER
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

    • Publication number 20200291003
    • Publication date Sep 17, 2020
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS

    • Publication number 20200270227
    • Publication date Aug 27, 2020
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

    • Publication number 20200216389
    • Publication date Jul 9, 2020
    • Inflazome Limited
    • David MILLER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    KINASE INHIBITORS

    • Publication number 20190330155
    • Publication date Oct 31, 2019
    • TOPIVERT PHARMA LIMITED
    • Thomas Matthew BAKER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    KINASE INHIBITORS

    • Publication number 20180319748
    • Publication date Nov 8, 2018
    • RESPIVERT LIMITED
    • Thomas Matthew BAKER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    KINASE INHIBITORS

    • Publication number 20180305383
    • Publication date Oct 25, 2018
    • Respivert Limited
    • Matthew Colin Thor FYFE
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    KINASE INHIBITORS

    • Publication number 20180044288
    • Publication date Feb 15, 2018
    • Respivert Limited
    • Thomas Matthew BAKER
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    KINASE INHIBITORS

    • Publication number 20170291917
    • Publication date Oct 12, 2017
    • Respivert Limited
    • Matthew Colin Thor FYFE
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    KINASE INHIBITORS

    • Publication number 20170253563
    • Publication date Sep 7, 2017
    • RESPIVERT LIMITED
    • Thomas Matthew BAKER
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE